Research

Mixed

Tirzepatide has surpassed semaglutide as the most commonly prescribed first-time GLP-1 RA medication in the US as of September 2025.

Tirzepatide is now the most frequently prescribed first-time GLP-1 medication in the US, overtaking semaglutide. This reflects changing prescribing preferences among physicians.

GoodSupportsHIGH confidence
Among first-time prescriptions for which use could be established... semaglutide was the most common first-time medication (n = 1,298,442), however in September 2025 tirzepatide is the most commonly prescribed first-time medication.
Samuel Gratzl et al. · medRxiv · 2025

Why this rating

Large sample size, real-world data.

Source

Monitoring Report: GLP-1 RA Prescribing Trends – March 2026 Data

Samuel Gratzl et al. · medRxiv · 2025

DOI 10.1101/2025.03.06.25323524

preprint · n=2454615Cited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →